CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 90 filers reported holding CUREVAC N V in Q1 2021. The put-call ratio across all filers is 1.24 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,349,193 | -37.6% | 1,808,081 | -4.8% | 0.01% | -40.0% |
| Q2 2023 | $19,787,153 | +158476.3% | 1,898,959 | +6.1% | 0.01% | +42.9% |
| Q1 2023 | $12,478 | +138.9% | 1,790,308 | +106.7% | 0.01% | +133.3% |
| Q4 2022 | $5,223 | -99.9% | 866,244 | +61.6% | 0.00% | +50.0% |
| Q3 2022 | $4,224,000 | -41.9% | 536,032 | +0.3% | 0.00% | -60.0% |
| Q2 2022 | $7,270,000 | -36.0% | 534,201 | -7.7% | 0.01% | -16.7% |
| Q1 2022 | $11,352,000 | +35.8% | 578,902 | +137.6% | 0.01% | +50.0% |
| Q4 2021 | $8,358,000 | -42.2% | 243,615 | -8.0% | 0.00% | -55.6% |
| Q3 2021 | $14,470,000 | -64.4% | 264,922 | -52.1% | 0.01% | -62.5% |
| Q2 2021 | $40,598,000 | +121.7% | 552,507 | +175.9% | 0.02% | +71.4% |
| Q1 2021 | $18,314,000 | +1751.8% | 200,235 | +1540.6% | 0.01% | +1300.0% |
| Q4 2020 | $989,000 | -93.0% | 12,205 | -96.0% | 0.00% | -94.1% |
| Q3 2020 | $14,181,000 | – | 304,637 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
| RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
| Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
| Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
| Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
| FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
| Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
| Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
| Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
| Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |